Why Axon Enterprise Shares Fell 3.3% Today

Axon Enterprise (AXON) is down 3.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver appears to be a mix of broad risk-off trading and stock-specific profit taking rather than a new fundamental setback. Axon has not posted an obvious negative corporate update this week, so the decline could be because investors reacted to the recent insider sale filing while also reducing exposure to richly valued growth stocks during a weaker market session.

Details:

Axon disclosed that President Joshua Isner sold 16,775 shares on August 31, 2026, in 28 transactions worth about $9.64 million, and the filing noted the sales were made under a pre-arranged Rule 10b5-1 plan.

Axon’s investor relations calendar showed management participating in the 2026 Wolfe Research TMT Conference on September 9, 2026, but no separate negative business announcement was evident from that listing.

Axon’s second-quarter 2026 results, released in early August, showed revenue of $904 million, up 35% year over year, which suggests today’s drop does not line up with a fresh earnings miss.

The broader backdrop was unfavorable for growth stocks, with the Nasdaq under pressure as oil moved above $100 per barrel and Treasury yields climbed, creating a tougher setting for premium-valued technology names.

Sources:

Axon Investor Relations, SEC, AP News

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$AXON Insider Trading Activity

$AXON insiders have traded $AXON stock on the open market 146 times in the past 6 months. Of those trades, 0 have been purchases and 146 have been sales.

Here’s a breakdown of recent trading of $AXON stock by insiders over the last 6 months:

PATRICK W SMITH (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 59 sales selling 50,000 shares for an estimated $26,926,875.
JOSHUA ISNER (PRESIDENT) has made 0 purchases and 47 sales selling 29,775 shares for an estimated $15,985,943.
JEFFREY C KUNINS (CPO & CTO) has made 0 purchases and 24 sales selling 9,605 shares for an estimated $6,019,433.
BRITTANY BAGLEY (COO & CFO) sold 5,969 shares for an estimated $2,894,965
ISAIAH FIELDS (Chief Legal Officer) sold 2,000 shares for an estimated $800,000
ELIZABETH REID COUGHLIN (Chief Human Officer) sold 1,554 shares for an estimated $753,690
CAMERON BROOKS (CHIEF REVENUE OFFICER) sold 1,242 shares for an estimated $621,000
JERI WILLIAMS has made 0 purchases and 3 sales selling 786 shares for an estimated $372,333.
CAITLIN ELIZABETH KALINOWSKI has made 0 purchases and 8 sales selling 564 shares for an estimated $270,140.
ERIKA NARDINI sold 198 shares for an estimated $100,302

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive AXON Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$AXON Hedge Fund Activity

We have seen 663 institutional investors add shares of $AXON stock to their portfolio, and 575 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

INVESCO LTD. added 1,994,642 shares (+161.6%) to their portfolio in Q2 2026, for an estimated $1,118,216,251
BAILLIE GIFFORD & CO added 1,416,909 shares (+86.3%) to their portfolio in Q2 2026, for an estimated $794,333,354
PRICE T ROWE ASSOCIATES INC /MD/ added 1,083,176 shares (+137.3%) to their portfolio in Q2 2026, for an estimated $607,239,297
EDGEWOOD MANAGEMENT LLC removed 903,748 shares (-44.6%) from their portfolio in Q2 2026, for an estimated $506,650,166
CAPITAL WORLD INVESTORS removed 781,518 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $438,126,805
JENNISON ASSOCIATES LLC removed 742,063 shares (-89.8%) from their portfolio in Q2 2026, for an estimated $416,007,938
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 647,298 shares (+inf%) to their portfolio in Q2 2026, for an estimated $362,881,731

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$AXON Government Contracts

We have seen $129,125,268 of award payments to $AXON over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

THE PURPOSE OF THIS DELIVERY ORDER IS TO PROCURE TASER CORE AND SUSTAINMENT PLANS IN SUPPORT OF ICE- OFFICE...: $5,777,050
TD 24066 TASER 10 CYCLICAL REPLACEMENT PLUS 6-BAY DOCK AND CORE, CONTRACT - 15M10424DA4700002 SHIPPING IN...: $4,684,195
INFORMATION TECHNOLOGY DIVISION (ITD) / BODY-WORN CAMERA PROGRAM OFFICE (BWCPO) ENTERPRISE LICENSE AGREEMEN...: $4,377,002
TASER SUPPLIES FOR CUSTOMS AND BORDER PROTECTION: $3,960,727

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

$AXON Congressional Stock Trading

Members of Congress have traded $AXON stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $AXON stock by members of Congress over the last 6 months:

SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/27.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$AXON Analyst Ratings

Wall Street analysts have issued reports on $AXON in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

JP Morgan issued a "Overweight" rating on 05/07/2026

To track analyst ratings and price targets for $AXON, check out Quiver Quantitative's $AXON forecast page.

$AXON Price Targets

Multiple analysts have issued price targets for $AXON recently. We have seen 8 analysts offer price targets for $AXON in the last 6 months, with a median target of $687.0.

Here are some recent targets:

Joshua Reilly from Needham set a target price of $750.0 on 07/06/2026
Trevor Walsh from Citizens set a target price of $700.0 on 06/25/2026
Tim Long from Barclays set a target price of $523.0 on 05/08/2026
James Fish from Piper Sandler set a target price of $674.0 on 05/07/2026
Joseph Cardoso from JP Morgan set a target price of $755.0 on 05/07/2026
Andrew Spinola from UBS set a target price of $440.0 on 05/07/2026
Michael Ng from Goldman Sachs set a target price of $625.0 on 04/08/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.